Louise A. Carter

Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

First-in-Human, Phase I/II Dose Escalation and Expansion Study of Zelenectide Pevedotin in Patients With Advanced Solid Tumors: Results From Monotherapy Dose Escalation.

First-in-Human, Phase I/II Dose Escalation and Expansion Study of Zelenectide Pevedotin in Patients With Advanced Solid Tumors: Results From Monotherapy Dose Escalation.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 06, 2025

UpSMART: five years of digital innovation in cancer clinical research-achievements, challenges, and recommendations.

UpSMART: five years of digital innovation in cancer clinical research-achievements, challenges, and recommendations.

Journal: Frontiers in digital health

Published: September 18, 2025

Expansion cohorts in phase 1 oncology trials: a systematic review of their design, implementation and outcomes.

Expansion cohorts in phase 1 oncology trials: a systematic review of their design, implementation and outcomes.

Journal: British journal of cancer

Published: July 27, 2025

Psychological Screening and Support for Patients Enrolled in Early-Phase Cancer Clinical Trials and the Possible Barriers: A Real-World Tertiary Center Implementation Study.

Psychological Screening and Support for Patients Enrolled in Early-Phase Cancer Clinical Trials and the Possible Barriers: A Real-World Tertiary Center Implementation Study.

Journal: Psycho-oncology

Published: June 07, 2025

"The Idea of Being Without It is Frightening". Uncertainty and Psychological Dependency for Patients Using Immuno-, Biological, or Precision Therapies: A Qualitative Study.

"The Idea of Being Without It is Frightening". Uncertainty and Psychological Dependency for Patients Using Immuno-, Biological, or Precision Therapies: A Qualitative Study.

Journal: Psycho-oncology

Published: May 14, 2025

Circulating Tumor DNA as a Prognostic Biomarker for Selecting Participants to Early Phase Clinical Trials.

Circulating Tumor DNA as a Prognostic Biomarker for Selecting Participants to Early Phase Clinical Trials.

Journal: Journal of immunotherapy and precision oncology

Published: April 17, 2025

Patient and Clinician Perspectives on the Communication of Genomic Results in Cancer Care.

Patient and Clinician Perspectives on the Communication of Genomic Results in Cancer Care.

Journal: Cancer medicine

Published: January 14, 2025

Development of the SCNS-TARGET: a new tool to assess unmet needs in cancer patients utilising immuno-, biological or precision therapies.

Development of the SCNS-TARGET: a new tool to assess unmet needs in cancer patients utilising immuno-, biological or precision therapies.

Journal: Journal of cancer survivorship : research and practice

Published: December 13, 2024

Real-world experience of Molecular Tumour Boards for clinical decision-making for cancer patients.

Real-world experience of Molecular Tumour Boards for clinical decision-making for cancer patients.

Journal: NPJ precision oncology

Published: October 06, 2024

A single centre experience of patients with rare cancers referred for early phase clinical trials.

A single centre experience of patients with rare cancers referred for early phase clinical trials.

Journal: BMC cancer

Published: September 30, 2024

Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors.

Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 04, 2024

"Oh when's your treatment ending?" "Never!" The unmet needs of cancer patients treated with immunological, biological and precision therapies: A qualitative interview study.

"Oh when's your treatment ending?" "Never!" The unmet needs of cancer patients treated with immunological, biological and precision therapies: A qualitative interview study.

Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society

Published: July 23, 2024

Showing 1-12 of 52

Last Updated: 09/26/2026